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Clinical prediction models to support the diagnosis of asthma
in primary care: a systematic review protocol
L. Daines 1, S. McLean1, A. Buelo2, S. Lewis3, A. Sheikh1 and H. Pinnock1
Substantial over-diagnosis and under-diagnosis of asthma in adults and children has recently been reported. As asthma is mostly
diagnosed in non-specialist settings, a clinical prediction model (CPM) to aid the diagnosis of asthma in primary care may help
improve diagnostic accuracy. We aim to systematically identify, describe, compare, and synthesise existing CPMs designed to
support the diagnosis of asthma in children and adults presenting with symptoms suggestive of the disease, in primary care
settings or equivalent populations. We will systematically search Medline, Embase and CINAHL from 1 January 1990 to present. Any
CPM derived for use in a primary care population will be included. Equivalent populations in countries without a developed primary
care service will also be included. The probability of asthma diagnosis will be the primary outcome. We will include CPMs designed
for use in clinical practice to aid the diagnostic decision making of a healthcare professional during the assessment of an individual
with symptoms suggestive of asthma. We will include derivation studies, and external model validation studies. Two reviewers will
independently screen titles/abstracts and full texts for eligibility and extract data from included papers. The CHARMS checklist (or
PROBAST if available) will be used to assess risk of bias within each study. Results will be summarised by narrative synthesis with
meta-analyses completed if possible. This systematic review will provide comprehensive information about existing CPMs for the
diagnosis of asthma in primary care and will inform the development of a future diagnostic model.
npj Primary Care Respiratory Medicine  (2018) 28:15 ; doi:10.1038/s41533-018-0086-6
BACKGROUND
Asthma is a chronic respiratory disease affecting an estimated 334
million people worldwide.1 Progress towards improving asthma
outcomes has been limited over the past decade.2 A key
determinant in providing optimal asthma care is accurate and
timely diagnosis. Yet, asthma remains a challenging disease to
diagnose and substantial over-diagnosis and under-diagnosis of
asthma in adults and children is reported.3–5 The consequences of
under-diagnosis are lack of treatment, avoidable morbidity and
mortality; while over-diagnosis leads to costly, potentially harmful
treatment and unnecessary healthcare use. Furthermore, to realise
the potential of precision medicine, greater accuracy in determin-
ing asthma traits at the point of diagnosis is required.2
Accurate diagnosis is challenging in a condition deﬁned by its
variability, in which the diagnosis is clinical, and in which
symptoms, signs, and tests have poor predictive value for the
diagnosis.6–8 The heterogeneity of asthma and recognition of
distinct phenotypes and endotypes, adds further complexity,2,9
particularly as variable airﬂow obstruction remains the core
diagnostic feature of asthma in current guidelines.7,8
Clinical prediction models (CPM), also referred to as prediction
rules or risk scores10 combine at least two predictors, such as
elements from a clinical history, physical examination, test results
or response to treatment, to estimate the probability that a certain
outcome is present.10,11 In clinical practice, CPMs can assist
healthcare professionals to weigh up the probability of a
diagnosis, enhance decision making with patients, or aid patient
stratiﬁcation.12–14
The current diagnostic strategies recommended in asthma
guidelines are based on expert consensus and in some instances
informed by health economic modelling, yet the accuracy with
which the advocated clinical assessment pathways result in a
correct diagnosis have not been formally evaluated.7,8,15
A prospectively validated CPM to support the diagnosis of
asthma would offer an evidence-based approach for the assess-
ment of individuals with symptoms suggestive of asthma. As most
asthma diagnoses occur in non-specialist settings,2 a CPM
developed for use in primary care (or equivalent settings where
undifferentiated health problems are presented to healthcare
professionals)16 would be particularly valuable.
To our knowledge, there are few CPMs to support the diagnosis
of asthma in primary care. Previous searches identiﬁed a symptom-
based diagnostic tool from South Korea,17 and an algorithm derived
from Japanese healthcare;18 neither have been externally validated.
A decision tree used to differentiate obstructive respiratory
conditions has been derived and validated in the Netherlands.19
To build on these foundations, inform future development and
progress towards wider implementation of a CPM for asthma
diagnosis in primary care, a systematic review is needed.
AIMS
To identify, describe, compare, and synthesise all CPMs designed
to support the diagnosis of asthma in children and adults
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presenting with symptoms suggestive of the disease, in primary
care settings or equivalent populations.
DISCUSSION
Accurately diagnosing asthma is pivotal for effective symptom
control and prevention of asthma attacks. By conducting this
systematic review of CPMs for the diagnosis of asthma in primary
care, we will critically appraise each included model, understand
the strengths and limitations of each study design and the utility
of each candidate predictor used, including signs and symptoms,
personal and family history, and results from past and current
clinical tests.
Although a CPM offers potential for improving the diagnosis of
asthma, a number of questions need to be addressed before it will
be accepted into clinical practice. Of fundamental importance is
the outcome measure used to derive the model. In the absence of
a “golden” reference standard for asthma diagnosis, the outcome
measure must be carefully considered if an accurate diagnosis is
to be made. Second, regardless of the statistical accuracy of a
model, to be clinically useful, its impact on clinical outcomes
should be tested, and healthcare professionals must trust the
model and want to use it.20,21 Finally, contemporary under-
standing of asthma as an aggregate diagnosis2,22 suggests that a
future diagnostic CPM may align with a precision medicine
approach, potentially being able to stratify individuals by treatable
traits.9 Our systematic approach will provide comprehensive
information about existing CPMs, and inform the future develop-
ment of a model for the diagnosis of asthma in primary care.
METHODS
The CHecklist for critical Appraisal and data extraction for systematic
Reviews of prediction Modelling Studies (CHARMS) has been used to
deﬁne the review question, and develop the review design.23 The Preferred
Reporting Items for Systematic Review and Meta-Analysis Protocols guided
protocol reporting.24
Data sources and search strategy
We will complete a systematic search to identify all studies describing
CPMs to support the diagnosis of asthma in primary care settings. In this
review, a CPM is deﬁned as any tool that combines at least two predictors,
to provide an estimate for the probability of an outcome.10,14
Medline, Embase, and CINAHL databases will be searched from 1
January 1990 to present. The search strategy (Appendix 1) uses Cochrane
asthma search syntax, with established search ﬁlters for prediction
models.25,26 CPMs published in national clinical guidelines will be sought
in TRIP (https://www.tripdatabase.com) and Guidelines Clearinghouse
(https://www.guideline.gov). Forward and backward citations from the
included studies will be searched for additional eligible studies. Interna-
tional experts and authors known to have published relevant work will be
contacted to identify further studies. No language restrictions will be used.
All studies will be translated into English where possible, any literature that
we are unable to translate will be declared.
Study eligibility criteria
Types of study. We will include derivation studies with or without external
validation, in addition to external model validation studies with or without
model updating.23
Population. Any CPM derived for use in a primary care population (or
equivalent) will be included.
Intervention (type of model). We will include CPMs designed for use in
clinical practice to aid the diagnostic decision making of a healthcare
professional during the assessment of an individual with symptoms
suggestive of asthma.
Comparator. There are no relevant comparators for this systematic
review.
Outcome to be predicted. The primary outcome is the probability of
asthma diagnosis. Included studies should present at least one prediction
model, or equivalent statistical method, in such a way that allows the
probability of asthma to be calculated for other individuals. Some CPMs
may use the broader outcome of obstructive airways disease. These studies
will be included if data pertaining to asthma diagnosis can be extracted.
CPMs derived for the diagnosis of occupational asthma will be included if
the intended use is to aid diagnostic decision making in patients with
undifferentiated symptoms.
Reference standard used to diagnose asthma. From scoping work, we
anticipate that studies designed to derive and validate asthma diagnosis
CPMs will use a variety of reference standards. We will evaluate the impact
of using different measures as the reference standard. However, studies
which do not use an internationally accepted deﬁnition for asthma will be
excluded.
Exclusion criteria. Studies will be excluded if:
1. The predictive value of more than one variable was evaluated but
not combined to produce a diagnostic estimate.
2. Publication occurred before 1 January 1990.
3. Variables used in the model are not available in routine clinical
practice or not clearly reported.
4. Outcomes for asthma are not separate or data relating to the
asthma outcome is not extractable.
5. The CPM was derived to predict future risk of asthma.
6. Over half of the participants included were children less than 5 years
old (because of the overlap between asthma and viral-associated
wheeze in this age group).
7. The reference standard used is not based on an internationally
recognised deﬁnition of asthma.
8. Non-original studies such as editorials, expert views, non-research
letters.
Data management and selection process
Records will be retrieved from databases and transferred into a reference
manager. Records will be de-duplicated, screened, and managed using
Covidence (https://www.covidence.org). Two reviewers (L.D., A.B.) will
independently screen titles and abstracts for eligibility. Full-text copies of
all potentially relevant records will be obtained. Two reviewers (L.D., A.B. or
S.McL.) will independently assess whether each full-text record meets the
inclusion criteria. Any discrepancies will be arbitrated by a third reviewer
(H.P., S.L., or A.S.).
Data extraction
Included articles will be categorised into two groups: derivation studies
and external model validation (with or without model updating). A
standardised data extraction form to collect relevant data items from
eligible studies will be developed and piloted in line with Cochrane and
CHARMS guidance.23 Data extraction will be undertaken by two reviewers
(L.D., S.McL.) who will independently extract relevant data from each
included study onto the data extraction form. Any disagreements will be
resolved by a third reviewer (H.P., S.L., or A.S.).
Data items
Data from the included studies will be summarised in descriptive tables.
Table 1 lists the minimum set of data items to be extracted. If a study
reports more than one model, we will extract data separately for each
model.
Critical appraisal and risk of bias in individual studies
The CHARMS checklist will guide risk of bias assessment within individual
studies.23 The prediction model risk of bias assessment tool (PROBAST) will
be used if available.27 Quality assessment will be used to evaluate whether
study quality makes any impression on the conclusions.
Data synthesis
Results will be summarised by narrative synthesis and descriptive statistics.
Methods for meta-analysis of model validation studies have recently been
reported28 and will be considered if suitable studies are identiﬁed.
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If possible, we will evaluate publication bias using Begg and Egger tests
and funnel plots.29,30
Evaluating conﬁdence in cumulative evidence
We will evaluate the overall evidence and strength of recommendations
gathered from the review using the Grading of Recommendations
Assessment, Development and Evaluation system.31
Protocol registration
A protocol will be registered with the International Prospective Register of
Systematic Reviews (PROSPERO). In the event of a protocol amendment,
the date, description, and rationale will be reported.
Data availability
Data sharing is not applicable as this article describes a protocol and no
datasets were generated or analysed.
ACKNOWLEDGEMENTS
We are grateful to Marshall Dozier, Academic Librarian at the University of Edinburgh,
for her help in developing the search strategy. L.D. is supported by a clinical
academic fellowship from Chief Scientist Ofﬁce, Edinburgh (CAF/17/01). Neither
funder nor sponsor (University of Edinburgh) contributed to protocol development.
AUTHOR CONTRIBUTIONS
L.D. and H.P. conceived the idea for this work supported by A.S. and S.L. L.D. wrote
the ﬁrst draft, and all authors contributed to the manuscript.
ADDITIONAL INFORMATION
Supplementary information accompanies the paper on the npj Primary Care
Respiratory Medicine website (https://doi.org/10.1038/s41533-018-0086-6).
Competing interests: A.S. is Joint Editor-in-Chief of npj: Primary Care Respiratory
Medicine, but was not involved in the editorial review of, nor the decision to publish,
this article. The remaining authors declare no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims
in published maps and institutional afﬁliations.
REFERENCES
1. Global Asthma Network. The Global Asthma Report 2014. http://globalasthmare-
port.org/index.php. (Auckland, New Zealand, 2014).
2. Pavord, I. D. et al. After asthma: redeﬁning airways diseases. Lancet. https://doi.
org/10.1016/ S0140-6736(17)30879-6 (2017).
3. Aaron, S. D. et al. Reevaluation of diagnosis in adults with physician-diagnosed
asthma. J. Am. Med. Assoc. 317, 269–279 (2017).
4. José, B. P. D. S., Camargos, P. A. M., Cruz Filho, Á. A. S. D., & Corrêa, R. D. A.
Diagnostic accuracy of respiratory diseases in primary health units. Rev. Assoc.
Med. Bras. 60, 599–612 (2014).
5. Looijmans-Van den Akker, I., van Luijn, K. & Verheij, T. Overdiagnosis of asthma in
children in primary care: a retrospective analysis. Br. J. Gen. Pract. 66, e152–e157
(2016).
6. Schneider, A. et al. Diagnostic accuracy of spirometry in primary care. BMC Pulm.
Med. 9, 31 (2009).
7. British Thoracic Society/Scottish Intercollegiate Guideline Network. British
Guideline on the Management of Asthma. http://www.sign.ac.uk/sign-153-brit-
ish- guideline-on-the-management-of-asthma.html (2016).
8. Global Initiative for Asthma. Global Strategy for Asthma Management and Pre-
vention. http://www.ginasthma.org (2017).
9. Agusti, A. et al. Treatable traits: toward precision medicine of chronic airway
diseases. Eur. Respir. J. 47, 410–419 (2016).
10. Toll, D. B., Janssen, K. J. M., Vergouwe, Y. & Moons, K. G. M. Validation, updating
and impact of clinical prediction rules: a review. J. Clin. Epidemiol. 61, 1085–1094
(2008).
11. Laupacis, A. & Sekar, N. Clinical prediction rules: a review and suggested mod-
iﬁcations of methodological standards. J. Am. Med. Assoc. 277, 488–494 (1997).
12. Steyerberg, E. Clinical Prediction Models: A Practical Approach to Development,
Validation, and Updating (Springer Science & Business Media, New York, USA,
2009).
13. Steyerberg, E. W. et al. Prognosis research strategy (PROGRESS) 3: prognostic
model research. PLoS Med. 10, e1001381 (2013).
14. Plüddemann, A. et al. Clinical prediction rules in practice: review of clinical
guidelines and survey of GPs. Br. J. Gen. Pract. 64, e233–e242 (2014).
15. National Institute for Health and Care Excellence: Asthma: Diagnosis, Monitoring
and Chronic Asthma Management. https://www.nice.org.uk/guidance/ng80 (2017).
16. Knottnerus, J. A. Between iatrotropic stimulus and interiatric referral: the domain
of primary care research. J. Clin. Epidemiol. 55, 1201–1206 (2002).
17. Choi, B. W. et al. Easy diagnosis of asthma: computer-assisted, symptom-based
diagnosis. J. Korean Med. Sci. 22, 832–838 (2007).
18. Tomita, K. et al. A scoring algorithm for predicting the presence of adult asthma:
a prospective derivation study. Prim. Care Respir. J. 22, 51–58 (2013).
19. Metting, E. I. et al. Development of a diagnostic decision tree for obstructive
pulmonary diseases based on real-life data. ERJ Open Res. 2, 00077–02015 (2016).
20. Wallace, E. et al. Framework for the impact analysis and implementation of
clinical prediction rules (CPRs). BMC Med. Inform. Decis. Mak. 11, 62 (2011).
Table 1. Minimum data items to be extracted from studies reporting model derivation or model validation
Data item Model derivation studies External model validation studies
Study author(s) and year of publication ✓ ✓
Country of study and publication language ✓ ✓
Source of funding and conﬂicts of interest ✓ ✓
Study design ✓ ✓
Study population ✓ ✓
Geographical location ✓ ✓
Number of participants ✓ ✓
Number of outcome events (asthma diagnosis conﬁrmed) ✓ ✓
Number and description of candidate predictors ✓
Deﬁnition and method used for measuring the outcome ✓ ✓
Number of participants with missing data ✓ ✓
Methods for handling missing values (e.g., imputation, complete case analysis) ✓ ✓
Methods for internally validating the model (e.g., bootstrapping, split-sample) ✓
How the model is presented (e.g., full or simpliﬁed equation, score chart) ✓
Measures of model performance (e.g., calibration, discrimination) ✓ ✓
Method of external validation (e.g., geographical, temporal) ✓
Study investigators (developers of the original model or not?) ✓
Clinical prediction models to support the diagnosis
L Daines et al.
3
Published in partnership with Primary Care Respiratory Society UK npj Primary Care Respiratory Medicine (2018)  15 
21. Wyatt, J. C. & Altman, D. G. Commentary: prognostic models: clinically useful or
quickly forgotten? Br. Med. J. 311, 1539–1541 (1995).
22. Belgrave, D. et al. Disaggregating asthma: big investigation versus big data. J.
Allergy Clin. Immunol. 139, 400–407 (2017).
23. Moons, K. G. et al. Critical appraisal and data extraction for systematic reviews of
prediction modelling studies: the CHARMS checklist. PLoS Med. 11, e1001744
(2014).
24. Shamseer, L. et al. Preferred reporting items for systematic review and meta-
analysis protocols (PRISMA-P): elaboration and explanation. Br. Med. J. 349, g7647
(2015).
25. Ingui, B. J. & Rogers, M. A. Searching for clinical prediction rules in MEDLINE. J.
Am. Medical Inform. Assoc. 8, 391–397 (2001).
26. Geersing, G. J. et al. Search ﬁlters for ﬁnding prognostic and diagnostic prediction
studies in Medline to enhance systematic reviews. PLoS ONE 7 e32844 (2012).
27. Wolff R, et al. PROBAST: a risk of bias tool for prediction modelling studies.
In Challenges to evidence-based health care and Cochrane. Abstracts of the
24th Cochrane Colloquium. https://abstracts.cochrane.org/2016-seoul/probast-
risk-bias-tool-prediction-modelling-studies. (John Wiley & Sons, Seoul, Korea 2016).
28. Debray, T. P. et al. A guide to systematic review and meta-analysis of prediction
model performance. Br. Med. J. 356, i6460 (2017).
29. Begg, C. B. & Mazumdar, M. Operating characteristics of a rank correlation test for
publication bias. Biometrics 50, 1088–1101 (1994).
30. Egger, M., Smith, G. D., Schneider, M. & Minder, C. Bias in meta-analysis detected
by a simple, graphical test. Br. Med. J. 315, 629–634 (1997).
31. Schünemann, H. J. et al. Rating quality of evidence and strength of recommen-
dations: GRADE: grading quality of evidence and strength of recommendations
for diagnostic tests and strategies. Br. Med. J. 336, 1106 (2008).
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in anymedium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly
from the copyright holder. To view a copy of this license, visit http://creativecommons.
org/licenses/by/4.0/.
© The Author(s) 2018
Clinical prediction models to support the diagnosis
L Daines et al.
4
npj Primary Care Respiratory Medicine (2018)  15 Published in partnership with Primary Care Respiratory Society UK
